Denial Management

Denial Management for Specialty &
Infusion Pharmacy

Root-cause analysis and payer-specific appeal playbooks for specialty pharmacy denials. Biologic, oncology, and rare disease appeals managed by therapy-trained specialists with an 80%+ appeal overturn rate.

30–40%

Denial reduction

80%+

Appeal overturn

PAYER-SPECIFIC

Playbooks

The Reality

Why Specialty Pharmacy Denials Are a Six-Figure Problem?

Large-Dollar Exposure

Specialty pharmacy denial rates run 18–28% — the highest in the industry. Each denied claim represents $5,000 to $50,000 in exposure. A single therapy class can accumulate seven-figure denial inventory in a quarter without dedicated appeals infrastructure.

Payer Policy Drift

Commercial and Medicare Advantage policies on specialty drugs change quarterly. Coverage criteria, step therapy requirements, and documentation standards shift. Denial reasons today are different from denial reasons six months ago — and templated appeals don't keep up.

Appeal Aging Risk

Specialty denials have payer-specific appeal windows ranging from 30 to 180 days. Miss the window and the claim is permanently lost. Without active aging discipline, denials sit in queue until they expire.

Clinical Documentation Gaps

Many specialty denials hinge on clinical evidence the pharmacy doesn't directly hold. Appeal infrastructure requires coordination with prescribers for chart notes, lab results, and prior treatment documentation — a logistics challenge most billing teams cannot run.

Generic Appeal Templates

Appeals built on generic templates lose. Appeals built on payer-specific policy citations, clinical evidence, and prescriber statements win. The difference is operational discipline most pharmacies don't have.

Root-Cause Blindness

Without root-cause analytics, the same denial reason recurs claim after claim. Effective denial management requires upstream feedback loops that fix the source, not just appeal the symptom.

Recent Client Results

Proof From The Field

A regional specialty pharmacy reduced overall denial rate from 22% to 7% within 90 days of go-live and recovered $1.8M in aged denials within the first six months. An oncology specialty pharmacy improved appeal overturn rate from 47% to 84% within 120 days by deploying AnnexMed’s payer-specific appeal playbooks. A rare disease specialty pharmacy serving 1,400 patients eliminated $720,000 in annual write-offs by establishing active denial aging discipline.

< 9%

Denial Rate
(vs. 18–28% industry)

80%+

Appeal Overturn
Rate

$1M+

Typical Aged Denial
Recovery Year One

How we support you

End-to-End Denial Management

AnnexMed runs denial management as a three-stage operation: triage, appeal, and prevention. Each stage staffed by therapy-trained specialists with payer-specific playbooks built from millions of specialty pharmacy claims.

Triage

Categorize and prioritize

Appeal

Win the recovery

Prevention

Stop denials at the source

Financial impact

What These Improvements Mean in Dollars?

For a specialty pharmacy with $40M–$80M annual revenue, integrated denial management drives $1M–$3M+ in annual financial benefit between active recovery, aged denial sweeps, and upstream prevention.

Improvement Area

Estimated Annual Impact

Denial Rate Reduction (22% → 7%)

$800K – $2.5M annually in recovered revenue

Aged Denial Recovery (first 6 months)

$500K – $2M in one-time revenue capture

Appeal Overturn Improvement (47% → 84%)

$400K – $1.2M annually in won appeals

Upstream Denial Prevention

$300K – $900K annually in prevented denials

Underpayment-Appeal Recovery

$200K – $700K annually in identified gaps

External Review Wins on High-Dollar Claims

$100K – $400K annually in escalated recovery

Performance Targets vs. Industry Benchmark

KPIs we hold ourselves accountable to — tracked in real time through your operational dashboards

Performance Metric

Industry Benchmark

AnnexMed Target

Specialty Pharmacy Denial Rate

Industry avg: 18–28%

< 9%

First-Pass Appeal Overturn

Industry avg: 40–55%

80%+

Aged Denial Recovery Rate

Industry avg: 25–40%

65%+

Days to Appeal Filing

Industry avg: 30–60 days

< 7 days

Appeal Window Expiration Rate

Industry avg: 8–18%

< 1%

Root-Cause Resolution Cycle

Industry avg: 90+ days

< 30 days

Why Annexmed?

In-House vs. AnnexMed Partnership

How the AnnexMed model compares to typical in-house or generalist billing operations:

In-House / Traditional

AnnexMed Partnership

Denial Triage Speed

Days to weeks; many denials age before review

Same-day triage with dollar-value prioritization

Appeal Templates

Generic across payers and therapies

Payer-specific playbooks built from millions of claims

Clinical Documentation

Pharmacy gathers ad hoc when needed

Standing prescriber coordination workflow

Aging Discipline

Manual; appeal windows missed routinely

Automated aging alerts; < 1% expiration rate

Root-Cause Analytics

Anecdotal; same denials recur

Continuous feedback loop to upstream operations

External Review Capacity

Rarely pursued; high-dollar denials written off

Routine escalation on high-dollar denials

Therapy-Class Expertise

Generalists across all therapies

Therapy-trained appeals specialists

Cost to Operate

Reactive staffing; expensive at scale

30–40% lower with scaled specialty expertise

Real cost example: Specialty pharmacy with $55M revenue, 22% denial rate baseline

In-House: $470,000 annual cost (4 FTE appeals specialists + supervision + documentation) + estimated $2.1M annual exposure (write-offs, missed windows, recurring root-cause denials). AnnexMed: $360,000 annual partnership fee + projected $2.6M annual financial benefit (denial reduction, recovery, prevention) = net annual financial benefit of approximately +$2.2M per year.

Technology

Powered by proprietary AI & analytics

AnnexMed’s technology stack was built for payer-specific operational demands, not adapted from provider-side billing tools. Risk adjustment accuracy, payment integrity, and credentialing compliance each require different data models, workflow logic, and reporting architectures than provider RCM. Our platform reflects that.

AI Agents & Automation

AI Agents & Intelligent Automation deploys autonomous AI agents across the full revenue cycle, automating eligibility verification, prior authorization, claims processing, payment posting, and denial management at hospital scale and speed.

Data & Analytics Platform

Data & Analytics Platform delivers real-time Power BI dashboards built for hospital executive visibility, including system-wide KPIs, service line performance, payer analysis, productivity, financial forecasting, and national benchmarking insights.

Intelligent AR Management

Intelligent AR Management handles A/R follow-up at hospital scale with intelligent worklists prioritized by dollar value and aging, payer-specific follow-up rules, automated escalation for high-value accounts, and full accountability for every claim.

Computer Assisted Coding

Computer Assisted Coding orchestrates hospital coding operation, intelligent chart assignment by service line, TAT tracking with SLA monitoring, quality audits with accuracy scoring, and coder performance management at enterprise scale.

Together, these platforms create a fully instrumented RCM operation where nothing falls through the cracks. You don’t interact with these systems directly, but the results they enable show up directly in your financial performance.

Ready to Turn Denial Management Into a Revenue Engine?

Most specialty pharmacies identify $1M–$3M in recoverable denials and prevented denial exposure in their first assessment. Schedule a no-obligation Denial Management Assessment.

Trusted by 100+ Healthcare Providers | AAPC, AHIMA & AAHAM Certified | SOC 2 Type II | HIPAA Compliant

Payer client outcomes

AnnexMed delivers measurable financial impact within the first 60 to 90 days of engagement. The following represent outcomes from active payer partnerships:

$15M–$40M

Risk
Adjustment

$18M–$50M

Payment
Integrity

6 Weeks

Credentialing Clearance

$15M–$50M+

Revenue
Impact

Case Studies

See the impact we deliver

Discover how AnnexMed reduces denials, accelerates reimbursements, and strengthens financial performance. Backed by measurable outcomes and proven RCM expertise, we deliver operational excellence, revenue stability, and sustainable growth you can trust.

Client Voices

See how our clients succeed

Hear from organizations that trust AnnexMed to reduce denials, accelerate reimbursements, and strengthen cash flow. Our expert support delivers measurable performance gains, operational efficiency, financial stability, and scalable growth.

Claims adjudication backlogs were delaying provider payments and increasing complaint volumes. AnnexMed took over processing, cleared the backlog in 30 days, and improved turnaround by 45%. Provider satisfaction scores climbed significantly, dispute volumes dropped, and our network relationships strengthened significantly.

Dr. Richard Calloway

Horizon Health Plan

Our payer operations team was overwhelmed with member inquiries, provider disputes, and claims rework. AnnexMed brought dedicated support that handled every function with accuracy and speed. Processing errors dropped by 60%, provider abrasion decreased, and our operational costs came down by nearly a third.

Dr. Priya Menon

Crestview Insurance Partners

Managing claims accuracy, provider data, and member support internally was draining our resources. AnnexMed streamlined our payer operations end to end. Claims processing improved, provider onboarding accelerated, and our administrative burden reduced dramatically. They understand payer complexity like no other partner.

Laura Simmons

Meridian Managed Care

Proven RCM expertise. Delivered at scale.

For over 20 years, AnnexMed has delivered RCM solutions nationwide, combining expert billing, coding, and AR support to drive measurable results and growth.

Hospital Solutions

RCM Partners Solutions

Practice Solutions

Payer Solutions

Pharmacy Solutions

Payer Services

Patient Access Services

Medical Coding Services

Revenue Cycle Operations

Revenue Recovery Solutions

Payer Services

Dental Services

Business Intelligence

Denial Management